Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study

BACKGROUND: Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection is associated with hypercoagulability caused by direct invasion of endothelial cells and\or proinflammatory cytokine release. Thromboprophylaxis with enoxaparin is recommended by current guidelines, but evidence is st...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:EClinicalMedicine
Auteurs principaux: Albani, Filippo, Sepe, Lilia, Fusina, Federica, Prezioso, Chiara, Baronio, Manuela, Caminiti, Federica, Di Maio, Antonella, Faggian, Barbara, Franceschetti, Maria Elena, Massari, Marco, Salvaggio, Marcello, Natalini, Giuseppe
Format: Artigo
Langue:Inglês
Publié: Elsevier 2020
Sujets:
Research paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7534836/
https://ncbi.nlm.nih.gov/pubmed/33043287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2020.100562
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires